SeqOnce BioSciences, Inc. — Form C-U (Regulation Crowdfunding)
SeqOnce BioSciences, Inc. of CARLSBAD, CA filed a Form C-U (Regulation Crowdfunding) with the SEC on 2025-05-07. Target raise $50K, up to $1.2M. Offered through OpenDeal Portal LLC.
Offering
- Filed: 2025-05-07
- Form: C-U
- Accession: 0001655808-25-000006
- Target amount: $50K
- Maximum amount: $1.2M
- Security type: Other
- Securities offered: 50,000
- Price: $1.0000
- Deadline: 2025-04-30
- Funding portal / intermediary: OpenDeal Portal LLC
- Intermediary file number: 007-00167
- Intermediary CRD: 283874
Issuer
- CIK: 0001655808
- Website: www.seqonce.com
- Legal status: Corporation
- Organized in: DE
- Incorporated: 2014-02-04
- Address: 1926 KELLOGG AVE,, CARLSBAD, CA, 92008
- Employees: 11
Financials (as filed)
- Total assets (most recent): $2.7M
- Cash (most recent): $255K
- Revenue (most recent): $2.6M
- Revenue (prior): $16.7M
- Net income (most recent): $-2.3M
- Net income (prior): $-1.5M
- Short-term debt: $1.5M
People (3)
| Name | Role | Location |
|---|
| Christopher Angermayer | Chief Executive Officer | Pasadena, CA |
| Christopher Angermayer | Director | Pasadena, CA |
| Joseph Dunham | Director | Pasadena, CA |
Reg CF filing history (2)
More